Problems of sexual function in patients with hypertension

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Since normal sexual physiology requires adequate function of the autonomic nervous system, sexual dysfunction is common in the hypertensive individual. Potency, i.e., the capacity to achieve and maintain erection, requires centrally mediated sympathetic outflow; ejaculation and orgasm depend on peripheral sympathetic function. Predictably, therefore, sympatholytic drugs cause impairment. Centrally active agents such as methyldopa, clonidine, and reserpine may impair potency in up to 32% of recipients. Failure of ejaculation is reported much less frequently, but delay of orgasm may occur in both men and women. Guanethidine, a peripherally active sympatholytic, produces abnormality of ejaculation in as many as 60% of recipients, depending on the dosage. Impotence may occur as a secondary 'psychogenic' result. The beta blocker propranolol can impair function, perhaps on a central basis, although it does so much less frequently. Diuretics can cause both impotence and failure of ejaculation in as many as 32% of recipients; the mechanisms are unclear. Only the vasodilators, and perhaps prazosin, are free of this complication. Significantly, 17% of 99 men with untreated hypertension reported abnormalities of function, whereas only 7% of age-matched normotensives had similar complaints. To ensure patient compliance, sexual dysfunction must be carefully managed through patient counseling and alteration of the drug regimen.

Original languageEnglish (US)
Pages (from-to)149-156
Number of pages8
JournalCardiovascular Medicine
Volume4
Issue number2
StatePublished - 1979
Externally publishedYes

Fingerprint

Ejaculation
Sympatholytics
Hypertension
Orgasm
Erectile Dysfunction
Methyldopa
Guanethidine
Prazosin
Reserpine
Autonomic Nervous System
Clonidine
Patient Compliance
Vasodilator Agents
Diuretics
Propranolol
Counseling
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Problems of sexual function in patients with hypertension. / Reichgott, Michael J.

In: Cardiovascular Medicine, Vol. 4, No. 2, 1979, p. 149-156.

Research output: Contribution to journalArticle

@article{7bfce92dd2f740489262be67d1d2b7bf,
title = "Problems of sexual function in patients with hypertension",
abstract = "Since normal sexual physiology requires adequate function of the autonomic nervous system, sexual dysfunction is common in the hypertensive individual. Potency, i.e., the capacity to achieve and maintain erection, requires centrally mediated sympathetic outflow; ejaculation and orgasm depend on peripheral sympathetic function. Predictably, therefore, sympatholytic drugs cause impairment. Centrally active agents such as methyldopa, clonidine, and reserpine may impair potency in up to 32{\%} of recipients. Failure of ejaculation is reported much less frequently, but delay of orgasm may occur in both men and women. Guanethidine, a peripherally active sympatholytic, produces abnormality of ejaculation in as many as 60{\%} of recipients, depending on the dosage. Impotence may occur as a secondary 'psychogenic' result. The beta blocker propranolol can impair function, perhaps on a central basis, although it does so much less frequently. Diuretics can cause both impotence and failure of ejaculation in as many as 32{\%} of recipients; the mechanisms are unclear. Only the vasodilators, and perhaps prazosin, are free of this complication. Significantly, 17{\%} of 99 men with untreated hypertension reported abnormalities of function, whereas only 7{\%} of age-matched normotensives had similar complaints. To ensure patient compliance, sexual dysfunction must be carefully managed through patient counseling and alteration of the drug regimen.",
author = "Reichgott, {Michael J.}",
year = "1979",
language = "English (US)",
volume = "4",
pages = "149--156",
journal = "Cardiovascular Medicine",
issn = "0199-6614",
number = "2",

}

TY - JOUR

T1 - Problems of sexual function in patients with hypertension

AU - Reichgott, Michael J.

PY - 1979

Y1 - 1979

N2 - Since normal sexual physiology requires adequate function of the autonomic nervous system, sexual dysfunction is common in the hypertensive individual. Potency, i.e., the capacity to achieve and maintain erection, requires centrally mediated sympathetic outflow; ejaculation and orgasm depend on peripheral sympathetic function. Predictably, therefore, sympatholytic drugs cause impairment. Centrally active agents such as methyldopa, clonidine, and reserpine may impair potency in up to 32% of recipients. Failure of ejaculation is reported much less frequently, but delay of orgasm may occur in both men and women. Guanethidine, a peripherally active sympatholytic, produces abnormality of ejaculation in as many as 60% of recipients, depending on the dosage. Impotence may occur as a secondary 'psychogenic' result. The beta blocker propranolol can impair function, perhaps on a central basis, although it does so much less frequently. Diuretics can cause both impotence and failure of ejaculation in as many as 32% of recipients; the mechanisms are unclear. Only the vasodilators, and perhaps prazosin, are free of this complication. Significantly, 17% of 99 men with untreated hypertension reported abnormalities of function, whereas only 7% of age-matched normotensives had similar complaints. To ensure patient compliance, sexual dysfunction must be carefully managed through patient counseling and alteration of the drug regimen.

AB - Since normal sexual physiology requires adequate function of the autonomic nervous system, sexual dysfunction is common in the hypertensive individual. Potency, i.e., the capacity to achieve and maintain erection, requires centrally mediated sympathetic outflow; ejaculation and orgasm depend on peripheral sympathetic function. Predictably, therefore, sympatholytic drugs cause impairment. Centrally active agents such as methyldopa, clonidine, and reserpine may impair potency in up to 32% of recipients. Failure of ejaculation is reported much less frequently, but delay of orgasm may occur in both men and women. Guanethidine, a peripherally active sympatholytic, produces abnormality of ejaculation in as many as 60% of recipients, depending on the dosage. Impotence may occur as a secondary 'psychogenic' result. The beta blocker propranolol can impair function, perhaps on a central basis, although it does so much less frequently. Diuretics can cause both impotence and failure of ejaculation in as many as 32% of recipients; the mechanisms are unclear. Only the vasodilators, and perhaps prazosin, are free of this complication. Significantly, 17% of 99 men with untreated hypertension reported abnormalities of function, whereas only 7% of age-matched normotensives had similar complaints. To ensure patient compliance, sexual dysfunction must be carefully managed through patient counseling and alteration of the drug regimen.

UR - http://www.scopus.com/inward/record.url?scp=0018749163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018749163&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0018749163

VL - 4

SP - 149

EP - 156

JO - Cardiovascular Medicine

JF - Cardiovascular Medicine

SN - 0199-6614

IS - 2

ER -